Olema Pharmaceuticals (OLMA) Stock Jumps on Rival’s Positive Cancer Trial Results

TLDR Olema Pharmaceuticals stock jumped 197.3% in pre-market trading Tuesday despite no company announcements Swiss drugmaker Roche reported positive Phase III trial results for giredestrant, a breast cancer treatment Olema is developing palazestrant, a similar drug for breast cancer treatment in partnership with Novartis Roche’s study met its primary endpoint in an interim analysis for [...]

The post Olema Pharmaceuticals (OLMA) Stock Jumps on Rival’s Positive Cancer Trial Results appeared first on Blockonomi.